Variceal Bleeding
Hemorrhage from esophageal or gastric varices, which are dilated blood vessels that develop due to portal hypertension in patients with cirrhosis. A life-threatening complication requiring urgent treatment with mortality rates up to 20% per episode.
Quick Answer
What it is
Hemorrhage from esophageal or gastric varices, which are dilated blood vessels that develop due to portal hypertension in patients with cirrhosis. A life-threatening complication requiring urgent treatment with mortality rates up to 20% per episode.
Key findings
- Grade A: Mortality Reduction (Variceal Bleeding) (Terlipressin (Terlivaz))
- Grade A: Bleeding Control (Variceal) (Terlipressin (Terlivaz))
Safety
- 34% relative risk reduction.
ℹ️ Quick Facts
Quick Facts: Variceal Bleeding
- Supplements Studied:1
1 supps · 2 outcomes
Detailed Outcomes
A
Mortality Reduction (Variceal Bleeding)
Cochrane meta-analysis (7 RCTs, 443 patients): Terlipressin reduced all-cause mortality vs placebo (RR 0.66, 95% CI 0.49-0.88). 34% relative risk reduction. The only vasoactive agent proven to reduce mortality in acute variceal hemorrhage.
large↓Improves
A
Bleeding Control (Variceal)
2018 meta-analysis (30 RCTs, 3344 patients): Terlipressin significantly improved bleeding control within 48h vs no vasoactive drug (OR 2.94, P=0.0008). Reduced need for emergency procedures (RR 0.72 vs placebo).
large↑Improves